Understanding how glucose transport is regulated in metabolic syndrome
Official title: Vesicle Translocation and the Metabolic Syndrome
Funded at Yale University · NIH-11039963 · Data updated 2026-11-12
This study looks at how insulin helps your body use sugar by focusing on a special protein that helps move sugar transporters to where they’re needed in your cells, and it aims to find out what goes wrong in people with insulin resistance, which could lead to better treatments for type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | April 1, 2022 |
| Project end | February 28, 2026 |
| Funding year | 2025 |
| Award (this year) | $516,235 |
| NIH project number | 5R01DK129466-04 |
| Project ID | NIH-11039963 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with insulin resistance, metabolic syndrome, or type 2 diabetes.
✕Less likely to help
Patients without metabolic disorders or those who do not have issues with glucose regulation may not benefit from this research.
What this research studies
This research investigates the mechanisms by which insulin regulates glucose uptake in muscle and fat cells, focusing on the role of a protein called TUG in the trafficking of GLUT4 glucose transporters. By examining how insulin triggers the movement of these transporters to the cell surface, the study aims to uncover the disruptions that lead to insulin resistance and metabolic syndrome. Patients may benefit from insights into how their bodies manage glucose, which could inform new treatment strategies for conditions like type 2 diabetes.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for managing blood sugar levels in patients with metabolic syndrome and type 2 diabetes.
How similar studies have gone: Previous research has shown promising results in understanding glucose transport mechanisms, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Bogan, Jonathan — Yale University
- Study coordinator: Bogan, Jonathan
Related research
Other NIH-funded projects on the same topics.
-
Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART
Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART
This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based therapy
This project looks at markers in pregnant women living with HIV who are on a DTG-containing regimen to understand why some develop metabolic problems during pregnancy.
-
Metabolic syndrome and brain support cells: how it may lead to Alzheimer’s disease
A researcher is studying how midlife metabolic problems like diabetes and obesity may disrupt brain cells that support neurons, potentially leading to Alzheimer's disease and related dementia in later life.
-
GLP-1 medicines to improve heart, kidney, and metabolic health for people with HIV and type 2 diabetes
A real-world study will look at how GLP-1 receptor agonists affect heart and kidney health and lifetime costs for people living with HIV and type 2 diabetes.
-
A new metabolic risk score to predict heart disease in Yup’ik Alaska Native adults
A new, questions-free way to measure heart-disease risk in Yup’ik Alaska Native adults by combining everyday health clues with home-life factors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.